Study S000642

Effect of Exenatide Treatment on Myocardial Fat Content, Left Ventricular Function, and Vascular Inflammation in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01951651
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 24
Start: 2010-04
Primary completion: 2012-10
Lead sponsor: Baylor College of Medicine
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Exenatide; DRUG:Glipizide
Results posted: TRUE

Registered primary outcomes

Myocardial Fat Content [6 months]
Hepatic Fat Content [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.